Eli Lilly Stock Rises After Profit, Outlook Top Expectations
Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...
Morgan Stanley Remains a Buy on Ultragenyx Pharmaceutical (RARE)
Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target ...
Major CT company rolls out new logo in age of smartphone communication. It’s name is changing too.
The Connecticut company’s long-lived logo is now getting a new look tailored for the future and the dramatic shift to digital ...
The MAHA movement in Congress: Who and what to watch
Robert F. Kennedy Jr’s message of eliminating toxins and investigating public health agencies has resonated among a key group ...
ChatGPT maker OpenAI now has a new logo to match its rebranding. This is what it looks like
OpenAI has made headlines on more than one occasion over the last few months. Firstly, it was due to the sudden emergence of ...
Novo Nordisk’s (NVO) CEO Is Not Worried About Government Price Negotiations
Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its ...
MicroStrategy rebrands to ‘Strategy’ and adopts Bitcoin logo
MicroStrategy, the business intelligence firm and Bitcoin treasury company co-founded by Michael Saylor has rebranded to ...
jacobin1d
RFK Jr is Wrong. Health Care is a Human Right.
In his confirmation hearing, Robert F. Kennedy Jr told Bernie Sanders that he opposes health care as a human right. His ...
Tariff threats take aim at fentanyl trafficking. Here's how the drug reaches the U.S.
President Donald Trump's threat of tariffs on goods from Mexico, Canada and China is aimed at stopping the flow of fentanyl ...
Newsday6d
AstraZeneca scraps plan to expand vaccine plant in the UK in blow to government
LONDON — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a ...
Innocan Pharma Corporation: Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone
HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...